Associations between migraine and cardiovascular disease

References

• Goadsby PJ, Lipton RB, Ferrari MD. Migraine – current understanding and treatment. N. Engl. J. Med.346, 257–270 (2002).
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Migraine. Lancet363, 381–391 (2004).
   PubMed Web of Science ®Google Scholar
• Hargreaves RJ, Shepheard SL. Pathophysiology of migraine – new insights. Can. J. Neurol. Sci.26(Suppl. 3), S12–S19 (1999).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine. Cephalalgia22, 107–111 (2002).
   PubMed Web of Science ®Google Scholar
• Collaborative Group for the Study of Stroke in Young Women. Oral contraceptives and stroke in young women: associated risk factors. JAMA231, 718–722 (1975).
   PubMed Web of Science ®Google Scholar
• Leon-Sotomayor LA: Cardiac migraine – report of twelve cases. Angiology25, 161–171 (1974).
   PubMedGoogle Scholar
• Uyarel H, Erden I, Cam N. Acute migraine attack, angina-like chest pain with documented ST-segment elevation and slow coronary flow. Acta Cardiol.60, 221–223 (2005).
   PubMed Web of Science ®Google Scholar
• Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology68, 1563–1570 (2007).
   PubMed Web of Science ®Google Scholar
• Henrich JB, Horwitz RI. A controlled study of ischemic stroke risk in migraine patients. J. Clin. Epidemiol.42, 773–780 (1989).
   PubMed Web of Science ®Google Scholar
• Tzourio C, Iglesias S, Hubert JB et al. Migraine and risk of ischaemic stroke: a case–control study. Br. Med. J.307, 289–292 (1993).
   PubMed Web of Science ®Google Scholar
• Carolei A, Marini C, De Matteis G. History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet347, 1503–1506 (1996).
   PubMed Web of Science ®Google Scholar
• Tzourio C, Tehindrazanarivelo A, Iglesias S et al. Case–control study of migraine and risk of ischaemic stroke in young women. Br. Med. J.310, 830–833 (1995).
   PubMed Web of Science ®Google Scholar
• Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case–control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Br. Med. J.318, 13–18 (1999).
   PubMed Web of Science ®Google Scholar
• Lidegaard O. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Br. J. Obstet. Gynaecol.102, 153–159 (1995).
   PubMedGoogle Scholar
• Mosek A, Marom R, Korczyn AD, Bornstein N. A history of migraine is not a risk factor to develop an ischemic stroke in the elderly. Headache41, 399–401 (2001).
   PubMedGoogle Scholar
• Donaghy M, Chang CL, Poulter N. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J. Neurol. Neurosurg. Psychiatry73, 747–750 (2002).
   PubMed Web of Science ®Google Scholar
• Schwaag S, Nabavi DG, Frese A et al. The association between migraine and juvenile stroke: a case–control study. Headache43, 90–95 (2003).
   PubMed Web of Science ®Google Scholar
• MacClellan LR, Giles WH, Cole J et al. Probable migraine with visual aura and risk of ischemic stroke: the Stroke Prevention in Young Women Study. Stroke38, 2438–2445 (2007).
   PubMed Web of Science ®Google Scholar
• Buring JE, Hebert P, Romero J et al. Migraine and subsequent risk of stroke in the Physicians’ Health Study. Arch. Neurol.52, 129–134 (1995).
   PubMed Web of Science ®Google Scholar
• Kurth T, Slomke MA, Kase CS et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology64, 1020–1026 (2005).
   PubMed Web of Science ®Google Scholar
• Stang PE, Carson AP, Rose KM et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology64, 1573–1577 (2005).
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Fenton BT, Cheng SH et al. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch. Neurol.54, 362–368 (1997).
   PubMed Web of Science ®Google Scholar
• Sochurkova D, Moreau T, Lemesle M et al. Migraine history and migraine-induced stroke in the Dijon stroke registry. Neuroepidemiology18, 85–91 (1999).
   PubMedGoogle Scholar
• Milhaud D, Bogousslavsky J, van Melle G, Liot P. Ischemic stroke and active migraine. Neurology57, 1805–1811 (2001).
   PubMed Web of Science ®Google Scholar
• Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. Br. Med. J.330, 63–65 (2005).
   PubMed Web of Science ®Google Scholar
• Diener HC, Kurth T. Is migraine a risk factor for stroke? Neurology64, 1496–1497 (2005).
   PubMedGoogle Scholar
• Osborn RE, Alder DC, Mitchell CS. MR imaging of the brain in patients with migraine headaches. AJNR Am. J. Neuroradiol.12, 521–524 (1991).
   PubMed Web of Science ®Google Scholar
• Igarashi H, Sakai F, Kan S et al. Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia11, 69–74 (1991).
   PubMed Web of Science ®Google Scholar
• Pavese N, Canapicchi R, Nuti A et al. White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia14, 342–345 (1994).
   PubMedGoogle Scholar
• De Benedittis G, Lorenzetti A, Sina C, Bernasconi V. Magnetic resonance imaging in migraine and tension-type headache. Headache35, 264–268 (1995).
   PubMed Web of Science ®Google Scholar
• Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch. Neurol.61, 1366–1368 (2004).
   PubMedGoogle Scholar
• Leviton A, Malvea B, Graham JR. Vascular diseases, mortality, and migraine in the parents of migraine patients. Neurology24, 669–672 (1974).
   PubMedGoogle Scholar
• Garcia-Albea E, Abarca M. Migraine and acute myocardial infarction. Neurologia8, 209–211 (1993).
   PubMedGoogle Scholar
• Mitchell P, Wang JJ, Currie J et al. Prevalence and vascular associations with migraine in older Australians. Aust. NZ J. Med.28, 627–632 (1998).
   PubMedGoogle Scholar
• Scher AI, Terwindt GM, Picavet HS et al. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology64, 614–620 (2005).
   PubMed Web of Science ®Google Scholar
• Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology62, 563–568 (2004).
   PubMed Web of Science ®Google Scholar
• Sternfeld B, Stang P, Sidney S. Relationship of migraine headaches to experience of chest pain and subsequent risk for myocardial infarction. Neurology45, 2135–2142 (1995).
   PubMed Web of Science ®Google Scholar
• Velentgas P, Cole JA, Mo J et al. Severe vascular events in migraine patients. Headache44, 642–651 (2004).
   PubMed Web of Science ®Google Scholar
• Rose KM, Carson AP, Sanford CP et al. Migraine and other headaches: associations with Rose angina and coronary heart disease. Neurology63, 2233–2239 (2004).
   PubMed Web of Science ®Google Scholar
• Ahmed B, Bairey Merz CN, McClure C et al. Migraines, angiographic coronary artery disease and cardiovascular outcomes in women. Am. J. Med.119, 670–675 (2006).
   PubMed Web of Science ®Google Scholar
• Kurth T, Gaziano JM, Cook NR et al. Migraine and risk of cardiovascular disease in women. JAMA296, 283–291 (2006).
   PubMed Web of Science ®Google Scholar
• Cook NR, Bensenor IM, Lotufo PA et al. Migraine and coronary heart disease in women and men. Headache42, 715–727 (2002).
   PubMedGoogle Scholar
• Kurth T, Gaziano JM, Cook N et al. Migraine and risk of cardiovascular disease in men. Arch. Intern. Med.167, 795–801 (2007).
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society: classification and diagnostic criteria for headache disorders cranial neuralgias and facial pain. Cephalalgia8, 1–96 (1988).
   Web of Science ®Google Scholar
• Welch KM, Levine SR. Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch. Neurol.47, 458–462 (1990).
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders (2nd Edition). Cephalalgia24(Suppl. 1), 9–160 (2004).
   PubMed Web of Science ®Google Scholar
• Tietjen GE. Migraine as a systemic disorder. Neurology68, 1555–1556 (2007).
   PubMed Web of Science ®Google Scholar
• Rose KM, Wong TY, Carson AP et al. Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study. Neurology68, 1694–1700 (2007).
   PubMed Web of Science ®Google Scholar
• Wilson PWF, D’Agostino RB, Levy D et al. Prediction of coronary heart disease using risk factor categories. Circulation97, 1837–1847 (1998).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology66, 545–550 (2006).
   PubMed Web of Science ®Google Scholar
• Kruit MC, van Buchem MA, Hofman PA et al. Migraine as a risk factor for subclinical brain lesions. JAMA291, 427–434 (2004).
   PubMed Web of Science ®Google Scholar
• Welch KM, Mathew NT, Stone P et al. Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalalgia20, 687–695 (2000).
   PubMed Web of Science ®Google Scholar
• Mathew NT, Hettiarachchi J, Alderman J. Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review. Headache43, 962–974 (2003).
   PubMed Web of Science ®Google Scholar
• Dodick DW, Martin VT, Smith T, Silberstein S. Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache44, S20–S30 (2004).
   PubMedGoogle Scholar
• Maassen Van Den Brink A, Saxena PR. Coronary vasoconstrictor potential of triptans: a review of in vitro pharmacologic data. Headache44(Suppl. 1), S13–S19 (2004).
   Google Scholar
• Martin VT, Goldstein JA. Evaluating the safety and tolerability profile of acute treatments for migraine. Am. J. Med.118(Suppl. 1), S36–S44 (2005).
   Google Scholar
• Wammes-van der Heijden EA, Rahimtoola H, Leufkens HG et al. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology67, 1128–1134 (2006).
   PubMed Web of Science ®Google Scholar
• Chan AT, Manson JE, Albert CM et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation113, 1578–1587 (2006).
   PubMed Web of Science ®Google Scholar
• Kurth T, Gaziano JM, Cook N et al. Are we ignoring the elephant in the room? – reply. Arch. Intern. Med. (2007) (In Press).
   Google Scholar
• Lea RA, Ovcaric M, Sundholm J et al. Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res. Mol. Brain Res.136, 112–117 (2005).
   PubMedGoogle Scholar
• Scher AI, Terwindt GM, Verschuren WM et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann. Neurol.59, 372–375 (2006).
   PubMed Web of Science ®Google Scholar
• Lanfear DE, Jones PG, Marsh S et al. β2-adrenergic receptor genotype and survival among patients receiving β-blocker therapy after an acute coronary syndrome. JAMA294, 1526–1533 (2005).
   PubMed Web of Science ®Google Scholar
• Siffert W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu. Rev. Med.56, 17–28 (2005).
   PubMed Web of Science ®Google Scholar
• Ferrario CM. The renin–angiotensin system: importance in physiology and pathology. J. Cardiovasc. Pharmacol.15(Suppl. 3), S1–S5 (1990).
   Web of Science ®Google Scholar
• Corella D, Ordovas JM. Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu. Rev. Nutr.25, 341–390 (2005).
   PubMed Web of Science ®Google Scholar
• MacCallum PK. Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers. Proc. Am. Thorac. Soc.2, 34–43 (2005).
   PubMedGoogle Scholar
• Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J. Am. Coll. Cardiol.41, S37–S42 (2003).
   PubMed Web of Science ®Google Scholar
• Diener HC, Kurth T, Dodick D. Patent foratmen ovale, stroke, and cardiovascular disease in migraine. Curr. Opin. Neurol.20, 310–319 (2007).
   PubMedGoogle Scholar
• Schwerzmann M, Wiher S, Nedeltchev K et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology62, 1399–1401 (2004).
   PubMed Web of Science ®Google Scholar
• Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet356, 1648–1651 (2000).
   PubMed Web of Science ®Google Scholar
• Dowson AJ, Wilmshurst P, Muir KW et al. A prospective, multicenter, randomized, double blind, placebo-controlled trial to evaluate the efficacy of patent foramen ovale closure with the STARFlex septal repair implant to prevent refractory migraine headaches: the MIST trial. Neurology67, 185 (2006).
   Google Scholar